Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI) - Amy Hai Yan Chan, Jo anna Hikaka, Edith To, Sarah Cullum, Etuini Ma’u, Brigid Ryan, Claudia Rivera-Rodriguez, Gary Cheung, 2022
Anti-dementia medications such as acetylcholinesterase inhibitors are an important part of the management pathway for dementia. However, there are limited data in New Zealand that have examined the rates and patterns of use of funded anti-dementia medication and how use differs with ethnicity, age and sex. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
